Predicine is a company developing a platform for molecular insights into cancer genomics. It offers GeneRADAR, a liquid biopsy platform that measures cancer-associated genomic blueprint and functional biology from urine and blood samples. The company also provides various assays for variant profiling, treatment selection, detection of gene fusions, and hematologic malignancies.